Page 15 - Serum Institute Of India

Covid-19 vaccination: COVAX in talks with govt to ensure speedy deliveries

SII is committed to supplying 200 million doses to the collaboration

India delays big exports of AstraZeneca vaccine as Covid-19 cases surge

India is, however, not officially banning Covid-19 vaccine exports. "This is a temporary move until the supply situation stabilises in the country," said a person close to the development

Adar Poonawalla rents London mansion for $69,000 a week, says report

The mansion is one of the largest residences in the neighborhood and measures about 25,000 square feet (2,322 square meters), the equivalent of about 24 average English homes

Supply slipping, Centre to speed up Covid-19 vaccine delivery to states

Vaccine makers asked to send more doses to central government on priority

One year on

Ravages of last year's lockdown may still affect economy

Will supply more doses of AstraZeneca vaccine to UK later, says Serum

Senior officials in New Delhi confirmed that there was no ban on exports from India, and no plans to do so either.

Will try to supply more jabs of Covid vaccine to UK later: Serum Institute

Last month, SII CEO Adar Poonawalla had urged other countries to be patient

Delay in Serum Institute vaccines contributing to supply squeeze: Britain

Britain is using vaccines made by Pfizer and AstraZeneca, with 10 million doses of the 100 million ordered from AstraZeneca coming from the Serum Institute.

Vaccine nationalism may hit WHO's 2021 goal of 2 bn doses: Adar Poonawalla

Countries are holding tight to their supplies and restricting access to materials needed to make more, said Adar Poonawalla, chief executive officer of the Serum Institute of India Ltd

India emerges global manufacturing hub for Covid-19 vaccine Sputnik V

Gland Pharma to make 252 mn doses, Hetero 100 mn doses, Strides may also join the fray

Govt places new purchase order with SII for 100 mn doses of Covishield

The price was fixed at Rs 157.50 a dose, including GST

Vaccinating India: What next?

We must pull out all the stops to win the race against the virus. And trust each other to do the right thing

Concerns over Oxford Covid-19 vaccine likely to impact export demand

Vaccine exports picked up last month; Serum shipped 11.9 mn to WHO-Gavi pool

Novavax's coronavirus vaccine 96% effective in UK late-stage trial

Company plans to produce its jab at eight sites, including Serum Institute

Adar Poonawalla-backed Svasti Microfinance to raise Rs 150 crore

This is likely to conclude by the third quarter of FY22, said Arunkumar Padmanabhan, co-founder of Svasti Micro­finance

Nepal receives 348,000 doses of made-in-India Covid-19 vaccines

The first COVAX shipment of 348,000 doses of AstraZeneca 'Covishield' vaccines arrived in Kathmandu, the embassy said in a tweet

SII seeks govt intervention over US ban on export of vaccine raw materials

US government has invoked the Defence Production Act because of which the firm is facing difficulties in importing necessary products, says director, government and regulatory affairs at Pune-based SI

India's massive Covid vaccine campaign boosted by PM Modi receiving shot

Almost 21 million shots have been administered in India so far, up from 5.4 million a month ago

Raw material shortage may affect scaling up of Covishield production

Last week, Adar Poonawalla had said on a World Bank panel that a US law blocking the export of key items like bags and filters will likely cause "serious bottlenecks" in vaccine production

10 mn doses from India won't impact poor nations' vaccine access, says UK

UK Vaccine Deployment Minister Nadhim Zahawi has defended a shipment of 10 million doses of Covishield en route from India amid some concerns that it would impact supplies of poorer nations